Active Filter(s):
Details:
Stabilitech Biopharma is seeking an investment of £6m to fund clinical trials and manufacturing of an oral coronavirus vaccine, OraPro-COVID-19.
Lead Product(s): OraPro-COVID-19
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: Preclinical Product Type: Vaccine
Partner/Sponsor/Collaborator: Undisclosed
Deal Size: $7.2 million Upfront Cash: Undisclosed
Deal Type: Funding April 20, 2020